61.45k followers • 20 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stocks that were bought the most by activist hedge funds in the last quarter.
Curated by Yahoo Finance
Follow this list to discover and track the stocks that were bought the most by activist hedge funds in the last quarter.
Background
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the global financial markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.
How are these weighted?The stocks in this watchlist are weighted equally.
Watchlist | Change today | 1-month return | 1-year return | Total return |
---|---|---|---|---|
Most bought by activist hedge funds | +0.73% | - | - | - |
^GSPC | +0.80% | +4.21% | +23.24% | +5574.74% |
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|---|---|---|---|---|---|---|---|
GS | The Goldman Sachs Group, Inc. | 456.52 | +6.29 | +1.40% | 4:00 pm GMT-4 | 2.61M | 2.34M | 147.21B |
SPGI | S&P Global Inc. | 427.51 | +5.92 | +1.40% | 4:00 pm GMT-4 | 1.69M | 1.33M | 133.77B |
ICE | Intercontinental Exchange, Inc. | 133.9 | +0.66 | +0.50% | 4:00 pm GMT-4 | 2.94M | 2.31M | 76.80B |
APO | Apollo Global Management, Inc. | 116.16 | -0.61 | -0.52% | 4:00 pm GMT-4 | 5.13M | 2.13M | 66.10B |
KVUE | Kenvue Inc. | 19.3 | +0.31 | +1.63% | 4:00 pm GMT-4 | 26.81M | 20.21M | 36.96B |
HPQ | HP Inc. | 36.5 | -1.86 | -4.85% | 4:00 pm GMT-4 | 29.62M | 8.09M | 35.72B |
IT | Gartner, Inc. | 419.67 | +5.19 | +1.25% | 4:00 pm GMT-4 | 741.92k | 390.45k | 32.58B |
IFF | International Flavors & Fragrances Inc. | 96.18 | +0.64 | +0.67% | 4:00 pm GMT-4 | 2.68M | 1.90M | 24.56B |
TEVA | Teva Pharmaceutical Industries Limited | 16.93 | +0.03 | +0.18% | 4:00 pm GMT-4 | 7.21M | 9.86M | 19.18B |
CPAY | Corpay, Inc. | 267.67 | +1.24 | +0.47% | 4:00 pm GMT-4 | 644.42k | 485.82k | 18.81B |
AER | AerCap Holdings N.V. | 92.71 | +0.85 | +0.93% | 4:00 pm GMT-4 | 1.28M | 1.60M | 18.39B |
WCC | WESCO International, Inc. | 179.49 | +0.63 | +0.35% | 4:00 pm GMT-4 | 769.10k | 724.77k | 9.12B |
KD | Kyndryl Holdings, Inc. | 26.61 | -0.03 | -0.11% | 4:00 pm GMT-4 | 1.63M | 1.77M | 6.13B |
ALIT | Alight, Inc. | 7.75 | +0.24 | +3.20% | 4:00 pm GMT-4 | 6.25M | 5.62M | 4.45B |
AAP | Advance Auto Parts, Inc. | 70.64 | +3.68 | +5.50% | 4:00 pm GMT-4 | 2.59M | 1.88M | 4.21B |
CLVT | Clarivate Plc | 5.7 | +0.08 | +1.42% | 4:00 pm GMT-4 | 5.53M | 4.46M | 3.81B |
SDRL | Seadrill Limited | 51.87 | +1.13 | +2.23% | 4:00 pm GMT-4 | 397.08k | 604.40k | 3.61B |
DHT | DHT Holdings, Inc. | 12.1 | -0.11 | -0.90% | 4:00 pm GMT-4 | 1.53M | 1.59M | 1.95B |
UAN | CVR Partners, LP | 81.79 | +0.46 | +0.57% | 4:00 pm GMT-4 | 15.01k | 45.85k | 864.49M |
Private credit has piqued the interest of major banks such as Goldman Sachs (GS) and Wells Fargo (WFC), with these financial institutions raising approximately $50 billion in private credit investments, according to a Bloomberg report. Yahoo Finance's Julie Hyman breaks down the private credit trend. For more expert insight and the latest market action, click here to watch this full episode of Asking for a Trend. This post was written by Angel Smith
TEL AVIV, Israel & PARSIPPANY, N.J., June 01, 2024--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of seven studies from its long-acting injectable (LAI) schizophrenia research program. Presentations include data informing clinical strategies for switching patients to UZEDY, an extended-release injectable suspension of risperidone for subcutaneous use every one or two months for the treatment of schizophrenia
TEL AVIV, Israel & PARSIPPANY, N.J., June 01, 2024--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new patient- and physician-reported interim results from the Phase 4 IMPACT-TD Registry study, reinforcing that TD has a wide-reaching, multidimensional impact on patients’ quality of life. These interim findings from the IMPACT-TD study were presented at the 2024 Psych Congress Elevate Annual Meeting, taking place from May 30 –